Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

CHOLINE C-11

CHOLINE C-11

Standard Dose
4-100mCi/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Discontinued
Summary

Approval overview CHOLINE C-11 is listed in Drugs@FDA under application 205690 (ANDA).

Review priority: UNKNOWN Marketing status: Discontinued Active ingredient CHOLINE C-11 Form and strength INJECTABLE;INTRAVENOUS - 4-100mCi/ML Sponsor UNIV TX MD ANDERSON Submission history Latest submission status date: 2017-07-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview CHOLINE C-11 is listed in Drugs@FDA under application 205690 (ANDA). Review priority: UNKNOWN Marketing status: Discontinued Active ingredient CHOLINE C-11 Form and strength INJECTABLE;INTRAVENOUS - 4-100mCi/ML Sponsor UNIV TX MD ANDERSON Submission history Latest submission status date: 2017-07-17 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: UNKNOWN

Interaction Notes

  • No interaction notes stored yet.